A few years ago, you mentioned a study on the idea that GLP-1 drugs might have a protective effect for people with ...
Up to one in three people with Parkinson's disease use at least one psychotropic medication, a recent study from the ...
A clinical trial in Oklahoma testing the drug Prasinezumab is offering new hope for people with Parkinson’s disease by aiming ...
Levodopa—the gold-standard treatment for Parkinson's disease—increases dopamine in the brain. But as the disease progresses ...
The disease, which affects 1.5 million people in the U.S., is characterized by tremors, rigid posture, loss of balance, and ...
The future of treating brain diseases could lie in non-invasive technologies, according to Chongqing Haifu Medical Technology ...
Not intended for UK Media Ametefgene parvec (AB-1005) manufactured at Viralgen commercial manufacturing facility with next-generation process to deliver high-purity product with greater efficiency ...
An experimental drug designed to silence a gene strongly linked to Parkinson's disease has shown encouraging effects in a ...
A large UK cohort study found that the epidemiology of Parkinsonism subtypes has shifted over time, with Parkinson’s disease showing a slight decline in incidence but a rise in prevalence, while ...
Analysis of microbes in the gut can reveal whether a person faces an elevated risk of Parkinson’s disease, before they have ...
Medtronic introduces Adaptive Deep Brain Stimulation system to aid Parkinson's disease patients, enhancing treatment options ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results